# Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)

Federal grant opportunity, via Kontrakk.

- **Agency:** National Institutes of Health
- **Opportunity number:** PAR-25-211
- **Status:** posted
- **Opens:** October 31, 2024
- **Closes:** June 2, 2027
- **CFDA:** 93.393, 93.121, 93.213, 93.313, 93.866
- **View on Kontrakk:** https://kontrakk.com/grants/356925

## Description

No description provided.